nach oben

Medical Oncology

Erschienen in:

01.03.2017 | Original Paper

Understanding venous malformations of the head and neck: a comprehensive insight

verfasst von: Giacomo Colletti, Anna Maria Ierardi

Erschienen in: Medical Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Venous malformations (VMs) are congenital vascular malformations. They are very often misnamed and thus incorrectly managed. The aim of the present paper is to provide the reader with the most updated literature available and to offer a detailed description of each single aspect of this disease. In detail, the paper discusses the epidemiology, the embryological origins and the physiopathology of VMs. Then, the clinical features of sporadic, inherited and syndromic VMs are discussed. The instrumental diagnosis is presented, and the role of US, CT, MRI and phlebography is pointed out. Differential diagnoses with other vascular malformations and tumors are described. The clinical session ends with the staging of VMs relying on MRI and rheological features. All aspects of treatment are described: conservative measures, medical treatment, sclerotherapy, laser and surgery are thoroughly discussed. A section is reserved to bony VMs. Their clinical aspects and the appropriate treatment are presented.

Colletti G, Deganello A. Cavernous hemangioma: a term to be canceled. Eur Arch Otorhinolaryngol. 2016. doi:10.1007/s00405-016-4324-7.PubMed

Vikkula M, Boon LM, Mulliken JB. Molecular genetics of vascular malformations. Matrix Biol. 2001;20(5):327–35.CrossRefPubMed

Legiehn GM, Heran MKS. Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin N Am. 2008;46(3):545–97.CrossRefPubMed

Luttun A, Carmeliet G, Carmeliet P. Vascular progenitors: from biology to treatment. Trends Cardiovasc Med. 2002;12(2):88–96.CrossRefPubMed

Tille JC. Hereditary vascular anomalies: new insights into their pathogenesis. Arterioscler Thromb Vasc Biol. 2004;24(9):1578–90.CrossRefPubMed

Risau W. Mechanisms of angiogenesis. Nature. 1997;386(6626):671–4.CrossRefPubMed

Cohen MM Jr. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet. 2006;140(19):2013–38.CrossRefPubMed

Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Helmbold EA, Markel DS, Vikkula M, Mulliken JB, Warman ML. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet. 1995;32(3):197–9.CrossRefPubMedPubMedCentral

Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol. 2004;140(8):971–6.CrossRefPubMed

10.

Vikkula M, Boon LM, Mulliken JB, Olsen BR. Molecular basis of vascular anomalies. Trends Cardiovasc Med. 1998;8(7):281–92.CrossRefPubMed

11.

Belov S. Classification, terminology and nosology of congenital vascular defects. Reinbek: Einhorn-Presse; 1989. p. 25–8.

12.

Jackson IT, Carreño R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg. 1993;91(7):1216–30.CrossRefPubMed

13.

Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol. 1997;36(2):219–25.CrossRefPubMed

14.

Dompmartin A, Acher A, Thibon P, Tourbach S, Hermans C, Deneys V, Pocock B, Lequerrec A, Labbé D, Barrellier M-T, Vanwijck R, Vikkula M, Boon LM. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873–7.CrossRefPubMed

15.

Blatt J, McLean TW, Castellino SM, Burkhart CN. A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations. Pharmacol Ther. 2013;139(3):327–33.CrossRefPubMed

16.

Shirazi F, Cohen C, Fried L, Arbiser JL. Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo. Lymphat Res Biol. 2007;5(4):233–6.CrossRefPubMed

17.

Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatric Blood Cancer. 2011;57(6):1018–24.CrossRefPubMed

18.

Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177–83.CrossRefPubMed

19.

Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9(2):267–85.CrossRefPubMed

20.

Marler JJ. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics. 2005;116(1):38–45.CrossRefPubMed

21.

Burrows PE, Mulliken JB, Fishman SJ, Klement GL, Folkman J. Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child. J Craniofac Surg. 2009;20(1):597–602.CrossRefPubMed

22.

Colletti G, Dalmonte P, Moneghini L, Ferrari D, Allevi F. Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations. Med Hypotheses. 2015;85(3):298–302.CrossRefPubMed

23.

Brouillard P, Boon LM, Mulliken JB, Enjolras O, Ghassibé M, Warman ML, Tan OT, Olsen BR, Vikkula M. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (‘glomangiomas’). Am J Hum Genet. 2002;70(4):866–74.CrossRefPubMedPubMedCentral

24.

Oranje AP. Blue rubber bleb nevus syndrome. Pediatr Dermatol. 1986;3(4):304–10.CrossRefPubMed

25.

Colletti G, Frigerio A, Giovanditto F, Biglioli F, Chiapasco M, Grimmer JF. Surgical treatment of vascular malformations of the facial bones. J Oral Maxillofac Surg. 2014;72(7):1326.e1–18.CrossRef

26.

Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, Warman ML. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet. 1994;3(9):1583–7.CrossRefPubMed

27.

Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA. 1971;68(4):820–3.CrossRefPubMedPubMedCentral

28.

Boon LM, Vikkula M. Multiple cutaneous and mucosal venous malformations. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–2017.

29.

Bean WB. Blue rubber-bleb nevi of the skin and gastrointestinal tract. In: Bean WB, editor. Vascular spiders and related lesions of the skin. Springfield: Charles C. Thomas; 1958. p. 178–85.

30.

Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg. 2000;37(8):517–84.CrossRefPubMed

31.

Yuksekkaya H, Ozbek O, Keser M, Toy H. Blue rubber bleb nevus syndrome: successful treatment with sirolimus. Pediatrics. 2012;129(4):e1080–4.CrossRefPubMed

32.

Gorham LW, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone): its relation to hemangiomatosis. J Bone Joint Surg Am. 1955;37(5):985–1004.CrossRefPubMed

33.

Jackson JB. A singular case of aborbtion of bone (a boneless arm). Boston Med Surg J. 1838;18:368–9.CrossRef

34.

Ruggieri P, Montalti M, Angelini A, Alberghini M, Mercuri M. Gorham–Stout disease: the experience of the Rizzoli Institute and review of the literature. Skelet Radiol. 2011;40(11):1391–7.CrossRef

35.

Hirayama T, Sabokbar A, Itonaga I, Watt-Smith S, Athanasou NA. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham–Stout disease. J Pathol. 2001;195(5):624–30.CrossRefPubMed

36.

Nozaki T, Nosaka S, Miyazaki O, Makidono A, Yamamoto A, Niwa T, Tsutsumi Y, Aida N, Masaki H, Saida Y. Syndromes associated with vascular tumors and malformations: a pictorial review. Radiographics. 2013;33(1):175–95.CrossRefPubMed

37.

Maffucci A. Di un caso di encondroma ed angioma multiplo. Mov Med Chir Napoli. 1881;3:399–412.

38.

Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, McCarthy S, Fantin VR, Straley KS, Lobo S, Aston W, Green CL, Gale RE, Tirabosco R, Futreal A, Campbell P, Presneau N, Flanagan AM. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet. 2011;43(12):1262–5.CrossRefPubMed

39.

Pansuriya TC, van Eijk R, d’Adamo P, van Ruler MAJH, Kuijjer ML, Oosting J, Cleton-Jansen A-M, van Oosterwijk JG, Verbeke SLJ, Meijer D, van Wezel T, Nord KH, Sangiorgi L, Toker B, Liegl-Atzwanger B, San-Julian M, Sciot R, Limaye N, Kindblom L-G, Daugaard S, Godfraind C, Boon LM, Vikkula M, Kurek KC, Szuhai K, French PJ, Bovée JVMG. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011;43(12):1256–61.CrossRefPubMedPubMedCentral

40.

Cai Y, Wang R, Chen X-M, Zhao Y-F, Sun Z-J, Zhao J-H. Maffucci syndrome with the spindle cell hemangiomas in the mucosa of the lower lip: a rare case report and literature review. J Cutan Pathol. 2013;40(7):661–6.CrossRefPubMed

41.

Verdegaal SHM, Bovée JVMG, Pansuriya TC, Grimer RJ, Ozger H, Jutte PC, San-Julian M, Biau DJ, van der Geest ICM, Leithner A, Streitbürger A, Klenke FM, Gouin FG, Campanacci DA, Marec-Berard P, Hogendoorn PCW, Brand R, Taminiau AHM. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011;16(12):1771–9.CrossRefPubMedPubMedCentral

42.

Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach–Merritt syndrome. Clin Lab Haematol. 2002;24(4):243–51.CrossRefPubMed

43.

Lee BB, Bergan J, Gloviczki P, Laredo J, Loose DA, Mattassi R, Parsi K, Villavicencio JL, Zamboni P, International Union of Phlebology (IUP). Diagnosis and treatment of venous malformations. Consensus document of the International Union of Phlebology (IUP)-2009. Int Angiol. 2009;28(6):434–51.PubMed

44.

Lee BB, Antignani PL, Baraldini V, Baumgartner I, Berlien P, Blei F, Carrafiello GP, Grantzow R, Ianniello A, Laredo J, Loose D, Lopez Gutierrez JC, Markovic J, Mattassi R, Parsi K, Rabe E, Roztocil K, Shortell C, Vaghi M. ISVI-IUA consensus document diagnostic guidelines of vascular anomalies: vascular malformations and hemangiomas. Int Angiol. 2015;34(4):333–74.PubMed

45.

Trop I, Dubois J, Guibaud L, Grignon A, Patriquin H, McCuaig C, Garel LA. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology. 1999;212(3):841–5.CrossRefPubMed

46.

Paltiel HJ, Burrows PE, Kozakewich HP, Zurakowski D, Mulliken JB. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology. 2000;214(3):747–54.CrossRefPubMed

47.

Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics. 2001;21(6):1531.CrossRef

48.

Dubois J, Garel L, David M, Powell J. Vascular soft-tissue tumors in infancy: distinguishing features on Doppler sonography. AJR Am J Roentgenol. 2002;178(6):1541–5.CrossRefPubMed

49.

Lee B-B, Choe YH, Ahn JM, Do YS, Kim D-I, Huh SH, Byun HS. The new role of magnetic resonance imaging in the contemporary diagnosis of venous malformation: can it replace angiography? J Am Coll Surg. 2004;198(4):549–58.CrossRefPubMed

50.

Weiss I, Lipari BA, Meyer L, Berenstein A, Waner M. Current treatment of parotid hemangiomas. Laryngoscope. 2011;121(8):1642–50.CrossRefPubMed

51.

Baker LL, Dillon WP, Hieshima GB, Dowd CF, Frieden IJ. Hemangiomas and vascular malformations of the head and neck: MR characterization. AJNR Am J Neuroradiol. 1993;14(2):307–14.PubMed

52.

Jarrett DY, Ali M, Chaudry G. Imaging of vascular anomalies. Dermatol Clin. 2013;31(2):251–66.CrossRefPubMed

53.

Eivazi B, Wiegand S, Negm H, Teymoortash A, Schulze S, Bien S, Werner JA. Orbital and periorbital vascular anomalies—an approach to diagnosis and therapeutic concepts. Acta Otolaryngol. 2010;130(8):942–51.CrossRefPubMed

54.

Gandolfo C, Krings T, Alvarez H, Ozanne A, Schaaf M, Baccin CE, Zhao W-Y, Lasjaunias P. Sinus pericranii: diagnostic and therapeutic considerations in 15 patients. Neuroradiology. 2007;49(6):505–14.CrossRefPubMed

55.

Akram H, Prezerakos G, Haliasos N, O’Donovan D, Low H. Sinus pericranii: an overview and literature review of a rare cranial venous anomaly (A review of the existing literature with case examples). Neurosurg Rev. 2011;35(1):15–26.CrossRefPubMed

56.

Jin YB, Lin XX, Chen H, Li W, Hu XJ, Ma G, Zhu L, Sun MH, Yang C, Wang W. Craniofacial venous malformations: magnetic resonance imaging features that predict treatment outcome. J Oral Maxillofac Surg. 2009;67(11):2388–96.CrossRefPubMed

57.

Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology. 2002;223(3):639–44.CrossRefPubMed

58.

Lee BB. Advanced management of congenital vascular malformations (CVM). Int Angiol. 2002;21(3):209–13.PubMed

59.

Lee BB. New approaches to the treatment of congenital vascular malformations (CVMs)—a single centre experience. Eur J Vasc Endovasc Surg. 2005;30(2):184–97.CrossRefPubMed

60.

Buckmiller LM, Richter GT, Suen JY. Diagnosis and management of hemangiomas and vascular malformations of the head and neck. Oral Dis. 2010;16(5):405–18.CrossRefPubMed

61.

McRae MY, Adams S, Pereira J, Parsi K, Wargon O. Venous malformations: clinical course and management of vascular birthmark clinic cases. Aust J Dermatol. 2012;54(1):22–30.CrossRef

62.

Redondo P. The hidden face of venous malformations: a multidisciplinary therapeutic approach. Arch Dermatol. 2008;144(7):922–6.CrossRefPubMed

63.

Hein KD, Mulliken JB, Kozakewich HPW, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110(7):1625–35.CrossRefPubMed

64.

O’Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol. 1997;169(3):723–9.CrossRefPubMed

65.

Cho KJ, Williams DM, Brady TM, Weiss CA, Forrest ME, Oke EJ, Griffin DJ. Transcatheter embolization with sodium tetradecyl sulfate. Experimental and clinical results. Radiology. 1984;153(1):95–9.CrossRefPubMed

66.

Govrin-Yehudain J, Moscona AR, Calderon N, Hirshowitz B. Treatment of hemangiomas by sclerosing agents: an experimental and clinical study. Ann Plast Surg. 1987;18(6):465–9.CrossRefPubMed

67.

Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med. 1993;119(8):819–27.CrossRefPubMed

68.

Donnelly LF, Bisset GS, Adams DM. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect. Pediatr Radiol. 2000;30(6):415–9.CrossRefPubMed

69.

Cabrera J, Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol. 2001;20(4):322–9.PubMed

70.

Shin BS, Do YS, Lee B-B, Kim D-I, Chung IS, Cho HS, Kim MH, Kim GS, Kim CS, Byun HS, Shin SW, Park KB. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology. 2005;235(3):1072–7.CrossRefPubMed

71.

Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001;27(1):58–60.PubMed

72.

Hou R, Guo J, Hu K, Yang Y, Wang L, Kong L, Liu G, Lei D. A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China. J Vasc Surg. 2010;51(4):940–5.CrossRefPubMed

73.

Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104(1):1–11 (discussion 12–5).CrossRefPubMed

74.

Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003;37(3):533–8.CrossRefPubMed

75.

Burrows PE. Endovascular treatment of slow-flow vascular malformations. Tech Vasc Interv Radiol. 2013;16(1):12–21.CrossRefPubMed

76.

Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg. 1997;31(2):145–50.CrossRefPubMed

77.

Barranco-Pons R, Burrows PE, Landrigan-Ossar M, Trenor CC, Alomari AI. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures. Am J Roentgenol. 2012;199(3):691–4.CrossRef

78.

Hammond B, Fairman RP, Monroe P, Glauser FL, Sugarman H, Davis D. The pulmonary hypertension of sclerosing agents is prevented by cyclooxygenase inhibitors. Am J Med Sci. 1985;290(3):98–101.CrossRefPubMed

79.

Allevi F, Rabbiosi D, Mandalà M, Colletti G. Paradoxical embolism following intralesional sclerotherapy for cervical venous malformation. BMJ Case Rep. 2014;2014. doi:10.1136/bcr-2014-206781.

80.

Lindsey SF, Reiders B, Mechaber HF. Life-threatening pharyngeal edema after sclerotherapy of oral venous malformations in a patient with blue rubber bleb nevus syndrome. J Dermatol Case Rep. 2013;7(3):74–6.CrossRefPubMedPubMedCentral

81.

Bekhor PS. Long-pulsed Nd:YAG laser treatment of venous lakes: report of a series of 34 cases. Dermatol Surg. 2006;32(9):1151–4.PubMed

82.

Suen JY, Waner M. Treatment of oral cavity vascular malformations using the neodymium:YAG laser. Arch Otolaryngol Head Neck Surg. 1989;115(11):1329–33.CrossRefPubMed

83.

Scherer K, Waner M. Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits. Lasers Med Sci. 2007;22(2):119–26.CrossRefPubMed

84.

John HE, Phen HS, Mahaffey PJ. Treatment of venous lesions of the lips and perioral area with a long-pulsed Nd:YAG laser. Br J Oral Maxillofac Surg. 2016;54(4):376–8. doi:10.1016/j.bjoms.2015.06.014.CrossRefPubMed

85.

Frigerio A, Tan OT. Laser applications for benign oral lesions. Lasers Surg Med. 2015;47(8):643–50.CrossRefPubMed

86.

Miyazaki H, Ohshiro T, Watanabe H, Kakizaki H, Makiguchi T, Kim M, Negishi A, Yokoo S. Ultrasound-guided intralesional laser treatment of venous malformation in the oral cavity. Int J Oral Maxillofac Surg. 2013;42(2):281–7.CrossRefPubMed

87.

Simon F, Le Clerc N, Salvan D, Sauvaget E, Faucon B, Borsik M, Herman P, Bisdorff A. Diode endovascular laser treatment in venous malformations of the upper aerodigestive tract. J Craniomaxillofac Surg. 2016;44(5):533–7. doi:10.1016/j.jcms.2016.02.007.CrossRefPubMed

88.

Philipp C, Berlien HP, Waldschmidt J. Lasers in pediatric surgery: a review. J Clin Laser Med Surg. 1991;9(3):189–94.PubMed

89.

Crockett DJ, Meier JD, Wilson KF, Grimmer JF. Treatment of oral cavity venous malformations with the Nd:YAG laser using the underwater technique. Otolaryngol Head Neck Surg. 2013;149(6):954–6.CrossRefPubMed

90.

Colletti G, Colombo V, Mattassi R, Frigerio A. Strangling technique to treat large cervicofacial venous malformations: a preliminary report. Head Neck. 2014;36(10):E94–8.PubMed

91.

Wiegand S, Tiburtius J, Zimmermann AP, Güldner C, Eivazi B, Werner JA. Localization and treatment of lingual venous and arteriovenous malformations. Vasc Med. 2014;19(1):49–53.CrossRefPubMed

92.

Leung M, Leung L, Fung D, Poon W-L, Liu C, Chung K, Tang P, Tse S, Fan T-W, Chao N, Liu K. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol. Eur J Pediatr Surg. 2014;24(1):097–101.CrossRef

93.

Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol. 2003;33(2):99–103.CrossRefPubMed

Titel: Understanding venous malformations of the head and neck: a comprehensive insight
verfasst von: Giacomo Colletti
Anna Maria Ierardi
Publikationsdatum: 01.03.2017
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 3/2017
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-017-0896-3

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Understanding venous malformations of the head and neck: a comprehensive insight

Abstract

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification

Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancer

Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?

Risk of tumor flare after nivolumab treatment in patients with irradiated field recurrence

Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization

Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie